• New Chinese Sequencer Promises 60 Human Genomes In A Day

    Oct 25, 2018, 10:10 AM by Michael Croft

    Bio- IT World News Brief | MGI Tech introduced the next iteration of its sequencer, the MGISEQ-T7, at the 13th International Conference on Genomics (ICG-13) in Shenzhen. The company also announced new library and sample prep and an application for tumor mutation detection.

    Full story
  • Certara’s Dr. Craig Rayner Awarded 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University

    Oct 24, 2018, 12:33 PM by Michael Croft
    PRINCETON, NJ - Oct 24, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that Craig Rayner, PharmD, MBA, senior vice president, integrated drug development with Certara Strategic Consulting, has been awarded the 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University
    Full story
  • Amazon Web Services Joins NIH’s STRIDES Initiative

    Oct 24, 2018, 08:10 AM by Michael Croft

    Bio-IT World News Brief | Amazon Web Services has joined NIH’s STRIDES Initiative to harness the latest cloud technologies for biomedical researchers.

    Full story
  • Reltio Announces Record Third Quarter, Major Company Milestones, and Key Executive Additions

    Oct 23, 2018, 18:28 PM by Michael Croft
    REDWOOD SHORES, CA - Oct 23, 2018 - Reltio, a leading provider of Modern Master Data Management and Customer 360 solutions, today announced the largest sales quarter in the company’s history, a series of company milestones, new management team members, and new Board of Director and Advisory Board members
    Full story
  • STEM Healthcare appoints Jason McKenna as CEO

    Oct 23, 2018, 11:08 AM by Michael Croft
    NEWCASTLE UPON TYNE, UNITED KINGDOM - Oct 23, 2018 -  Global benchmarking company STEM Healthcare (STEM) is pleased to announce the appointment of Jason McKenna as CEO
    Full story
  • Creative Biolabs Released the Unmatchable Diabody for Clinical Use

    Oct 23, 2018, 10:49 AM by Michael Croft
    SHIRLEY, NY - Oct 23, 2018 - Oct 22, 2018, as an unchallenged experience in antibody production, Creative Biolabs is always holding the faith of providing high-quality products and services to clients all over the world
    Full story
  • Kindred Biosciences Elects Denise Bevers to its Board of Directors and Promotes Her to President

    Oct 23, 2018, 10:18 AM by Michael Croft
    SAN FRANCISCO, CA - Oct 23, 2018 - Kindred Biosciences Elects Denise Bevers to its Board of Directors and Promotes Her to PresidentKindred Biosciences, Inc
    Full story
  • News And Notes From ASHG 2018

    Oct 23, 2018, 07:00 AM by Michael Croft

    Bio-IT World | The American Society of Human Genetics (ASHG) hosted their annual meeting last week in San Diego, California. Here are some of the announcements made during the meeting.

    Full story
  • Creative Diagnostics Launches Time-resolved Fluorescent Microspheres for Molecular Applications

    Oct 23, 2018, 03:47 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Oct 23, 2018 - With years of experience in the pharmaceutical and life science sector, Creative Diagnostics recently launches superior brightness europium (Eu) chelate polystyrene nanoparticles in diameter of 0-400 nm to address the needs of Point-of-Care (POC), diagnostic lateral flow and other time-resolved fluorescent microspheres, which have great potential applications in lateral flow assays, Point-of-Care (POC), diagnostic assay, immunochromatographic and microplate-based formats, molecular biology, nucleic acid, hybridizations, and immuno/histological research
    Full story
  • Rho Supports Pediatric Heart Transplantation Study

    Oct 22, 2018, 12:03 PM by Michael Croft
    CHAPEL HILL - Oct 22, 2018 - For Immediate Release Rho Supports Pediatric Heart Transplantation StudyCRO serves as the Statistical and Clinical Coordinating Center for NIH-sponsored study Chapel Hill, NC  ̶  October 22, 2018  Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, is part of a newly published study that is helping medical professionals better understand pediatric heart transplantation
    Full story
  • WEGO Health Announces Winners of the 2018 WEGO Health Awards at Annual Connected Health Conference

    Oct 19, 2018, 13:20 PM by Michael Croft
    BOSTON, MA, US - Oct 18, 2018 - WEGO Health, the world’s largest network of patient thought leaders and health influencers, today announced the winners of its seventh annual WEGO Health Awards at a live ceremony held in conjunction with the 2018 Connected Health Conference in Boston
    Full story
  • BOC Sciences Diversifies Immune Checkpoint Inhibitors and Nonspecific Immune Stimulation for Cancer Immunotherapy

    Oct 19, 2018, 02:31 AM by Michael Croft
    SHIRLEY, NY, NY, UNITED STATES - Oct 10, 2018 - The world’s reputed chemical supplier BOC Sciences recently announced to diversify its immune checkpoint inhibitors as well as nonspecific immune stimulation targets for scientific research targeting cancer immunotherapy
    Full story
  • WEGO Health Announces Winners of the 2018 WEGO Health Awards at Annual Connected Health Conference

    Oct 18, 2018, 17:10 PM by Michael Croft
    BOSTON, MA, US - Oct 18, 2018 - WEGO Health, the world’s largest network of patient thought leaders and health influencers, today announced the winners of its seventh annual WEGO Health Awards at a live ceremony held in conjunction with the 2018 Connected Health Conference in Boston
    Full story
  • eClinical Solutions LLC Expands elluminate Clinical Data Hub

    Oct 18, 2018, 14:37 PM by Michael Croft
    MANSFIELD, MA, UNITED STATES - Oct 18, 2018 - eClinical Solutions LLC, a leading global provider of cloud based software for clinical research and software driven clinical data services, announced the latest version of elluminate is available for general use
    Full story
  • Synpromics Promoter Technology Moves Closer to the Clinic

    Oct 18, 2018, 07:37 AM by Michael Croft
    EDINBURGH, UK - Oct 18, 2018 - Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European Society of Gene and Cell Therapy conference in Lausanne, Switzerland
    Full story
  • Thermo Fisher Scientific CE Marks Oncomine Dx Target Test

    Oct 17, 2018, 11:52 AM by Michael Croft
    CARLSBAD, CA, UNITED STATES - Oct 17, 2018 - Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumors
    Full story
  • Evonetix named Best Synthetic Biology Company at OBN Awards

    Oct 17, 2018, 09:57 AM by Michael Croft
    CAMBRIDGE, UK - Oct 12, 2018 - CAMBRIDGE, UK, 12 October 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has received the award for “Best Emerging Synthetic Biology Company” at the 10th Anniversary of the Oxford Bioscience Network (OBN) Awards, in recognition of the Company’s novel gene synthesis technology, and its potential to facilitate the rapidly growing field of synthetic biology
    Full story
  • Opportunity Identification - Zeroing In On The Most Promising Targets

    Oct 17, 2018, 08:00 AM by Michael Croft

    Bio-IT World Contributed Commentary | When tackling opportunity identification, life science and biotech companies need to look at services and technology platforms that can leverage data collection to come up with a targeted list of opportunities and bring on a senior team to develop relationships with them before and after the automated data crunching.

    Full story
  • Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform

    Oct 17, 2018, 06:39 AM by Michael Croft
    EDINBURGH, UK - Oct 17, 2018 - Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, Switzerland
    Full story
  • Tjoapack and Veratrak launch EPOCH initiative

    Oct 16, 2018, 15:22 PM by Michael Croft
    ETTEN LEUR, NETHERLANDS - Sep 9, 2018 - Global contract packaging and supply chain organisation (CPO), Tjoapack and UK-based technology company, Veratrak, have launched the European Platform on Changing Healthcare (EPOCH) as part of their ongoing partnership dedicated to improving pharmaceutical supply chain operations
    Full story